## Clinical Stratification of Hyperkalemia This patient has **asymptomatic hyperkalemia** (K⁺ = 6.8 mEq/L) **without ECG changes**. The management differs fundamentally from symptomatic disease. ## Hyperkalemia Severity Classification | Severity | K⁺ Level | ECG Changes | Symptoms | Management | |---|---|---|---|---| | **Mild** | 5.5–6.0 | None | None | Dietary restriction, address cause | | **Moderate** | 6.0–7.0 | None or peaked T | None or mild | Kayexalate, diuretics, insulin/dextrose | | **Severe** | > 7.0 or any level with ECG changes | Peaked T, PR ↑, QRS ↑, ST depression | Palpitations, weakness, syncope | **Calcium + insulin/dextrose + dialysis** | **Key Point:** The **presence of ECG changes** (not the absolute K⁺ level) determines urgency. This patient's normal ECG despite K⁺ = 6.8 means she is in the **moderate asymptomatic category**. ## Management Algorithm for Asymptomatic Hyperkalemia ```mermaid flowchart TD A[K⁺ 6.0-7.0 mEq/L]:::outcome --> B{ECG changes?}:::decision B -->|Yes| C[Calcium + Insulin/Dextrose<br/>+ Dialysis]:::urgent B -->|No| D{Symptoms?}:::decision D -->|Yes| E[Insulin/Dextrose + Kayexalate<br/>Plan dialysis]:::action D -->|No| F[Kayexalate + Diuretics<br/>Address underlying cause]:::action F --> G[Recheck K⁺ in 24 hrs]:::outcome G --> H{K⁺ controlled?}:::decision H -->|Yes| I[Continue medical management]:::action H -->|No| J[Dialysis]:::urgent ``` ## Why This Patient Does NOT Need Immediate Dialysis **High-Yield:** Dialysis is reserved for: 1. **Symptomatic hyperkalemia with ECG changes** (life-threatening) 2. **Refractory hyperkalemia** (fails medical therapy within 24 hours) 3. **Concurrent acute kidney injury** requiring RRT 4. **Severe metabolic acidosis** (pH < 7.1) with hyperkalemia This patient is **asymptomatic with normal ECG**—she can be managed medically first. ## Optimal Medical Management for This Patient ### Step 1: Shift K⁺ Intracellularly - **Insulin 10 units IV + 25 g dextrose** (or 500 mL 5% dextrose) - Onset: 10–20 minutes - Reduction: 0.5–1.2 mEq/L - Safe even in mild acidosis ### Step 2: Bind K⁺ in GI Tract - **Sodium polystyrene sulfonate (kayexalate) 15–30 g PO/PR** - Onset: 2–12 hours - Reduction: 0.5–1.0 mEq/L - Removes K⁺ from body (not just shifted) ### Step 3: Address Underlying Cause - **Discontinue spironolactone** (potassium-sparing diuretic) - **Reconsider lisinopril** (ACE inhibitor reduces renal K⁺ excretion) - **Optimize furosemide** (increases renal K⁺ loss, but limited efficacy in CKD) ### Step 4: Arrange Dialysis If Needed - If K⁺ does not fall to < 6.0 mEq/L within 24 hours → **hemodialysis** - If K⁺ rises again despite medical therapy → **long-term dialysis planning** **Clinical Pearl:** In CKD patients on ACE inhibitors + spironolactone, hyperkalemia is common and often **recurrent**. This patient may ultimately need dialysis, but a 24-hour trial of medical therapy is appropriate in the asymptomatic setting. ## Why Each Distractor Is Wrong **Option A (Immediate Dialysis):** Dialysis is not indicated for asymptomatic hyperkalemia without ECG changes. It is invasive, requires vascular access, and should be reserved for symptomatic or refractory cases. **Option B (Discontinue drugs + kayexalate + increase furosemide):** While discontinuing spironolactone is correct, kayexalate alone is too slow (2–12 hours). Increasing furosemide in CKD stage 4 is ineffective. Insulin/dextrose is missing—the fastest intracellular shift agent. **Option D (Observe without intervention):** K⁺ = 6.8 mEq/L is not safe to observe. Even asymptomatic hyperkalemia can deteriorate rapidly, especially in CKD. Active medical therapy is needed.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.